enhances muscle protein mass associated with maintaining Akt-mTOR-FOXO1 signaling and suppressing TLR4 and NOD2 signaling in piglets challenged with LPS.
SKELETAL MUSCLE composes 60 to 70% of lean body mass and is, therefore, an abundant source of both amino acids and energy substrates during times of need (12) . During sepsis and infection, skeletal muscle protein degradation is enhanced to support the hepatic acute phase response and provide gluconeogenic substrates (12) . Muscle protein synthesis is also inhibited to maintain energy reserves (12) . The concurrent loss of existing muscle protein due to increased protein degradation and new protein due to decreased protein synthesis results in muscle atrophy or cachexia, which are associated with critical illness and infection or poor quality of life (9, 12) .
It has been well demonstrated that activation of skeletal muscle inflammatory signaling pathways play a key role in muscle atrophy during sepsis and infection (12) . Among inflammatory signaling pathways, Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain proteins (NODs) are two of the important protein families (15, 42) . Among the TLR family, TLR4 is the most studied member, which is responsible for recognizing endotoxin or LPS from Gramnegative bacteria (15, 42) . Among the NODs family, NOD1 and NOD2 are the best characterized members, which possess the ability to connect with the LPS and peptidoglycan, and to transduce a TLR-independent signal (15) . In porcine, TLR4 has been extensively investigated (19, 49) , and molecular cloning and functional characterization of NOD1 and NOD2 have been performed (45, 46) . Multiple TLRs and NODs are expressed in the skeletal muscle cells (12, 43) . They play major roles in the detection of microbial infection and the induction of innate antibacterial and inflammatory responses by recognition of pathogen-associated molecular patterns (PAMPs) (15, 42) . Activation of TLRs or NODs by interaction with their specific PAMPs triggers downstream signaling pathways that results in activation of nuclear factor-B (NF-B). Activation of NF-B further provokes the expression of pro-inflammatory genes, including tumor necrosis factor-␣ (TNF-␣), interleukin (IL)-1␤, and IL-6 (15) . These pro-inflammatory cytokines are key regulators that induce muscle atrophy directly (14) . In addition, these cytokines have been shown to suppress the muscle protein kinase Akt (6) . The inactivation of Akt inhibits muscle protein synthesis through mammalian target of rapamycin (mTOR) signaling pathway (12) and enhances muscle protein degradation through the nuclear transcription factors termed Forkhead Box O (FOXO) and FOXO target genes, such as muscle-specific ubiquitin ligases, muscle atrophy F-box (MAFbx), and muscle RING finger 1 (MuRF1) (6, 9) , resulting in muscle wasting (12) .
Glycine is the simplest amino acid with only two carbon atoms. Traditionally, it is often considered as a nutritionally nonessential amino acid in mammals because of the presence of its endogenous synthesis in the body (53) . However, recent studies have indicated that glycine plays an important role in many physiological and biological processes (59) . First, gly-cine works as a neurotransmitter in the central nervous system, and glycine receptor has been identified in nerve cells (3) . In addition, some studies have shown that glycine is an effective anti-inflammatory agent (17, 59) . Glycine supplementation results in activation of glycine-gated Cl Ϫ channels in inflammatory cells, mediating an influx of Cl Ϫ into the cell, thereby making voltage-gated Ca 2ϩ channels more difficult to open and alleviating the increases in intracellular Ca 2ϩ ([Ca 2ϩ ] i ), cytokine production, and systemic inflammation in several models of diseases (59) . Moreover, some studies have shown that glycine is effective in treatment and prevention of muscle atrophy. For example, Ham et al. (17) reported that glycine supplementation alleviated skeletal muscle wasting in a mouse model of cancer cachexia. However, to our knowledge the molecular mechanism(s) by which glycine attenuates skeletal muscle wasting remain to be elucidated.
In view of the foregoing, we hypothesized that dietary glycine addition could reduce the production of muscle proinflammatory cytokines via regulating inflammatory signaling pathways, and thus protect against muscle atrophy through maintenance of Akt-mTOR-FOXO signaling. In this experiment, Escherichia coli lipopolysaccharide (LPS) was injected to establish the model of endotoxemia (6) . In addition, we utilized a weanling pig model, which is a good animal model for human nutrition research (7, 39) . Our aim in this study was to investigate whether glycine could mitigate LPS-induced muscle atrophy, and to explore its molecular mechanism(s).
MATERIALS AND METHODS
Animal care and diets. The animal handing procedures were approved by the Animal Care and Use Committee of Wuhan Polytechnic University. Twenty-four healthy weaned crossbred barrows (Duroc ϫ Large White ϫ Landrace), with similar body weight [7.1 Ϯ 0.4 kg initial body weight (BW)] and age (28 Ϯ 1 days), were randomly assigned to four treatments. The pigs with the same sex were used for keeping animal uniformity. There were six replicate pens per treatment and one pig per replicate. The piglets were housed individually in metabolism cages, each fitted with water nipples and creep feeders. The ambient temperature was controlled by air conditioner and maintained at 22-25°C. The basal diet (Table 1) was formulated to meet nutrient requirements for the piglets according to the National Research Council (33) .
Experimental design. The experiment included four treatment groups: 1) a nonchallenged control (CONTR; piglets fed a control diet and injected with 0.9% NaCl solution); 2) an LPS-challenged control [LPS; piglets fed the same control diet and injected with Escherichia coli LPS (Escherichia coli serotype 055: B5; Sigma Chemical, St. Louis, MO)]; 3) an LPSϩ1.0% glycine group (piglets fed a 1.0% glycine-supplemented diet and injected with LPS); and 4) an LPSϩ2.0% glycine group (piglets fed a 2.0% glycine-supplemented diet and injected with LPS). We chose the dose of glycine (purity Ͼ 99.5%; Amino Acid Bio-Chemical, Wuhan, China), according to a previous study in milk-fed young pigs by Wang et al. (52) , in which the piglet receiving 0.5, 1.0, and 2.0% glycine had increased body weight, daily weight gain and protein accretion, and decreased plasma concentrations of ammonia, urea, and glutamine in a dose-dependent manner. In addition, 0.5, 1.0, and 2.0% glycine increased intestinal villus height, intestinal transport of glycine, and plasma concentrations of glycine and glutathione (52) . To get isonitrogenous diets, we added 2.38, 1.19, and 0% alanine (purity Ͼ 99%; Amino Acid Bio-Chemical) to the control, 1.0% glycine, and 2.0% glycine-supplemented diets, respectively. After receiving the control, 1.0% glycine and 2.0% glycine-supplemented diets for 28 days, the pigs were given an intraperitoneal injection of LPS at 100 g/kg BW or the same volume of 0.9% NaCl solution. The LPS dose was used according to our previous studies (25, 28, 29) , which demonstrated that this dose of LPS caused acute tissue injury in weaned pigs. After administration with LPS or 0.9% NaCl solution, all piglets were deprived of feed until slaughter to avoid the potential effects of LPS-caused feed intake reduction on variables in blood and muscle. The piglets were allowed ad libitum access to water.
Blood and muscle sample collections. Four hours after injection of either LPS or saline, blood samples were obtained from the anterior vena cava and centrifuged to harvest plasma. Plasma was kept at Ϫ80°C for later analysis. After blood collection was completed, all piglets were euthanized by intramuscular injection of pentobarbital sodium (80 mg/kg BW). The gastrocnemius and longissimus dorsi (LD) muscles were harvested under the semitendinosus and biceps flexor cruris (left hind leg) and from the 10th rib (right side of the carcass), respectively. The muscle samples were frozen immediately in liquid nitrogen, and then stored at Ϫ80°C for further analysis. A sampling time of 4 h was chosen according to previous studies, which found that LPS resulted in tissue damage and increased levels of circulating or tissue pro-inflammatory cytokine within 3-6 h after LPS challenge (1, 8, 26, 29, 47) . In addition, elevated mRNA (57) and protein levels (26, 57) of TLR4 were also observed during this timeframe.
Plasma levels of TNF-␣, cortisol, glucagon, and glucose. Plasma TNF-␣ level was determined by using a commercially available porcine ELISA assay kit (PTA00; R&D Systems, Minneapolis, MN). Plasma cortisol and glucagon levels were analyzed with 125 I RIA assay kits (cortisol, D10PZB; glucagon, F03PZB; Beijing North Institute of Biological Technology, Beijing, China). Plasma glucose level was determined by the glucose GOD-PAP assay kit (No. 11225070201; DiaSys Diagnostic Systems, Germany). All experimental procedures were conducted according to the manufacturer's recommendations.
The contents of muscle DNA, RNA, and protein. The contents of DNA, RNA, and protein in muscles were measured as previously described (29) .
Real-time PCR measurement. Total RNA extraction, quantification, reverse transcription, and real-time quantitative PCR were conducted according to the method as previously described (28) . Briefly, total RNA was extracted from muscle samples with the TRIzol reagent (No. 108, TaKaRa Biotechnology, Dalian, China). RNA concentration and purity were spectrophotometrically measured at OD260 and OD280. RNA integrity was verified by agarose gel electrophoresis. cDNA synthesis was performed with a PrimeScript RT reagent kit with gDNA eraser (No. RR047A, TaKaRa Biotechnology). Quantitative analysis of PCR was carried out on a ABI 7500 Real-Time PCR System (Applied Biosystems, Life Technologies) with a SYBR Premix Ex TaqTM (Tli RNaseH Plus) qPCR kit (No. RR420A, TaKaRa Biotechnology). Cycling conditions were 95°C ϫ 30 s, followed by 40 cycles of 95°C ϫ 5 s and 60°C ϫ 34 s. The primers used for real-time PCR are presented in Table 2 . The primers of Akt1 and FOXO1 were designed from the pig gene sequences in GenBank. The sequences of other PCR primers were designed according to previous studies (22, 25, 58) . Quantitative PCR efficiencies of these primers used were close to 100% in this experiment. The PCR products of different primers were verified by agarose gel electrophoresis and sequencing. The relative abundance of the target genes vs. GAPDH (the housekeeping gene) was figured out by using the formula 2 Ϫ⌬⌬CT (30). We tested several housekeeping genes by analyzing gene stability according to the method of Vandesompele et al. (50) . We found the expression of GAPDH to be more stable than that of other housekeeping genes, and there was no difference in the expression of GAPDH among the four treatments or the two muscles. Relative mRNA abundance of every target gene was normalized to the control group.
Western blotting measurement. Protein immunoblot analysis was carried out according to the method described previously (28) . Briefly, the muscle samples (150 -200 mg) were homogenized in 600 l of lysis buffer with protease inhibitors included and centrifuged at 12,000 g for 15 min at 4°C to collect supernatants. Equal amounts of protein (65 g) were transferred onto polyacrylamide gel and separated via SDS-PAGE, and then transferred to polyvinylidene difluoride membranes for immunoblotting. Immunoblots were blocked with 5% nonfat milk in Tris-buffered saline/Tween-20 for 3 h at room temperature. The membranes were incubated overnight at 4°C with primary antibodies, and then with the secondary antibody for 2 h at room temperature. Specific primary antibodies included total Akt (t-Akt and visualized with a Gene Genome bioimaging system. Bands were analyzed by densitometry using GeneTools software (Syngene). Phosphorylated forms of Akt, mTOR, 4E-BP1, and FOXO1 were normalized with their abundance, i.e., the total protein contents of Akt, mTOR, 4E-BP1, and FOXO1.
Eight samples from four treatments (n ϭ 2) were run in one gel. Thus 24 samples from four treatments (n ϭ 6) were run in three gels FOXO, Forkhead box O; IRAK1, IL-1 receptor-associated kinase 1; MAFbx, muscle atrophy F-box; mTOR, mammalian target of rapamycin; MuRF1, muscle RING finger 1; MyD88, myeloid differentiation factor 88; NF-B, nuclear factor-B; NOD, nucleotide-binding oligomerization domain protein; RIPK2, receptor-interacting serine/threonine-protein kinase 2; TLR, Toll-like receptor; TNF-␣, tumor necrosis factor-␣; TRAF6, TNF receptor-associated factor 6; 4E-BP1, eukaryotic initiation factor 4E binding protein 1.
at one time to minimize the variations of gel to gel. The analyses were conducted in duplicate.
Statistical analysis. All data were analyzed by ANOVA by using the general linear model procedures of SAS (SAS Institute, Cary, NC) for randomized complete-block design. Differences between means were determined by Duncan's multiple range tests. Results were presented as means Ϯ SE. Differences were considered as significant when P Յ 0.05.
RESULTS
Growth performance. Throughout the 28-day feeding trial (before LPS challenge), no differences were observed in initial (7.1 Ϯ 0.4 kg) and final BW (21.4 Ϯ 1.1 kg), average daily gain (509 Ϯ 27 g), average daily feed intake (1,019 Ϯ 52 g), and gain-to-feed ratio (0.54 Ϯ 0.02) among the four treatments.
Plasma concentrations of TNF-␣, cortisol, glucagon, and glucose. The LPS challenge induced fever, shivering, vomiting, anorexia, and inactivity within 1 h in all piglets (data not shown). Compared with CONTR piglets, the LPS pigs had higher plasma TNF-␣, cortisol, and glucagon concentrations (P Ͻ 0.05; Table 3 ). Compared with LPS pigs, the LPSϩ1.0% and 2.0% Glycine (Gly) pigs had lower plasma TNF-␣ and cortisol concentrations (P Ͻ 0.05). However, relative to the CONTR pigs, the LPSϩ1.0% and 2.0% Gly pigs still had higher plasma TNF-␣ and cortisol concentrations (P Ͻ 0.05).
Muscle protein, DNA, and RNA concentrations. The LPS pigs did not differ significantly in protein, RNA, and DNA concentrations, and RNA/DNA and protein-to-DNA ratios (protein/DNA) in gastrocnemius and LD muscles from the CONTR pigs (P Ͼ 0.05; Table 4 ). Compared with LPS pigs and the CONTR pigs, the LPSϩ1.0% Gly pigs had higher RNA/DNA and protein/DNA ratios and lower DNA concentration in gastrocnemius muscle, and higher protein concentration and protein/DNA ratio in LD muscle (P Ͻ 0.05). The LPSϩ2.0% Gly pigs had higher protein concentration and RNA/DNA and protein/DNA ratios and lower DNA concentration in gastrocnemius muscle, and higher protein concentration and protein/DNA ratio in LD muscle (P Ͻ 0.05).
Muscle mRNA expression of the key genes in Akt-mTOR-FOXO pathways. Relative to CONTR piglets, the LPS pigs had lower mRNA abundance of Akt1 in LD muscle and higher mRNA abundance of FOXO1 and MuRF1 in gastrocnemius and LD muscles (P Ͻ 0.05; Table 5 ). Compared with LPS pigs, the LPSϩ1.0% Gly pigs had lower mRNA abundance of FOXO1 in LD muscle, and MAFbx and MuRF1 in gastrocnemius muscle (P Ͻ 0.05). The LPSϩ2.0% Gly pigs had lower mRNA expression of FOXO1 in gastrocnemius and LD muscles, and MAFbx and MuRF1 in gastrocnemius muscle (P Ͻ 0.05). Compared with CONTR pigs, the LPSϩ1.0% or 2.0% Gly pigs still had higher mRNA expression of FOXO1 in LD muscle, and MuRF1 in gastrocnemius muscle (P Ͻ 0.05), but had even lower mRNA expression of MAFbx in gastrocnemius muscle (P Ͻ 0.05).
Muscle protein phosphorylation of the key genes in AktmTOR-FOXO pathways. Compared with CONTR piglets, the LPS pigs had lower ratios of p-Akt/t-Akt and p-mTOR/tmTOR in gastrocnemius muscle, p-4E-BP1/t-4E-BP1 in gastrocnemius and LD muscles, and p-FOXO1/t-FOXO1 in LD muscle (P Ͻ 0.05; Figs. 1, 2, 3 , and 4). Compared with LPS pigs, the LPSϩ1.0% Gly pigs had higher ratios of p-Akt/t-Akt and p-mTOR/t-mTOR in gastrocnemius muscle (P Ͻ 0.05). Values are means Ϯ SE, n ϭ 6 (1 pig/pen). Labeled means in a row without a common letter differ, P Ͻ 0.05. Gly, glycine; TNF-␣, tumor necrosis factor-␣; ND, not detectable, lower than the minimum detectable dose of TNF-␣. Values are means Ϯ SE, n ϭ 6 (1 pig/pen). Labeled means in a row without a common letter differ, P Ͻ 0.05. LD, longissimus dorsi.
The LPSϩ2.0% Gly pigs had higher ratios of p-Akt/t-Akt and p-mTOR/t-mTOR in gastrocnemius muscle, and p-FOXO1/t-FOXO1 in LD muscle (P Ͻ 0.05). Relative to the CONTR pigs, the LPSϩ1.0% pigs had similar ratios of p-Akt/t-Akt and p-mTOR/t-mTOR in gastrocnemius muscle (P Ͼ 0.05). The LPSϩ2.0% Gly pigs had similar ratios of p-Akt/t-Akt in gastrocnemius muscle and p-FOXO1/t-FOXO1 in LD muscle (P Ͼ 0.05), and an even higher ratio of p-mTOR to t-mTOR in gastrocnemius muscle (P Ͻ 0.05).
Muscle mRNA abundance of TLR4 and NODs and their downstream signals.
Compared with CONTR piglets, the LPS pigs had higher mRNA abundance of TLR4, myeloid differentiation factor 88 (MyD88), NOD2, receptor-interacting serine/ threonine protein kinase 2 (RIPK2), and TNF-␣ in gastrocnemius muscle (P Ͻ 0.05; Table 6 ), and MyD88, NOD2 and RIPK2 in LD muscle (P Ͻ 0.05). Compared with LPS pigs, the LPSϩ1.0% Gly pigs had lower mRNA abundance of TLR4, IL-1 receptor-associated kinase 1 (IRAK1), NOD2, RIPK2, and TNF-␣ in gastrocnemius muscle, and MyD88, NOD2, and TNF-␣ in LD muscle (P Ͻ 0.05). The LPSϩ2.0% Gly pigs had lower mRNA abundance of TLR4, MyD88, IRAK1, TNF receptor-associated factor 6 (TRAF6), NOD2, and RIPK2 in gastrocnemius muscle, and MyD88, TRAF6, NOD2, and TNF-␣ in LD muscle (P Ͻ 0.05). Relative to the CONTR pigs, the LPSϩ1.0% pigs still had higher mRNA abundance of 
TLR4, NOD2
, and RIPK2 in gastrocnemius muscle (P Ͻ 0.05), but similar mRNA abundance of TNF-␣ in gastrocnemius muscle, and MyD88 and NOD2 in LD muscle (P Ͼ 0.05), and even lower mRNA abundance of IRAK1 in gastrocnemius muscle and TNF-␣ in LD muscle (P Ͻ 0.05). The LPSϩ2.0% pigs had similar mRNA abundance of TLR4, MyD88, NOD2, and RIPK2 in gastrocnemius muscle, and MyD88 and NOD2 in LD muscle (P Ͼ 0.05), and even lower mRNA abundance of IRAK1 and TRAF6 in gastrocnemius muscle and TRAF6 and TNF-␣ in LD muscle (P Ͻ 0.05).
DISCUSSION
Glycine is one of the most abundant amino acids in the plasma of suckling pigs and gestating gilts (11, 27, 56) . Glycine has multiple physiological functions in animals (53) . Of particular interest, increasing evidence has shown that glycine exerts beneficial effects in several models of muscle atrophy, such as cancer cachexia (17) and calorie restriction (5) . Based on this, we explored the effect of glycine on the markers of muscle atrophy after a 4-h Escherichia coli LPS challenge in a piglet model. LPS, an outer membrane component of Gram-negative bacteria, is a potent endotoxin. Various studies have demonstrated that LPS administration decreases muscle protein synthesis and increases protein degradation, decreases muscle mass and muscle fiber area, and induces muscle atrophy (6, 24, 37, 51) . The pathogenesis of LPSinduced muscle atrophy is closely correlated with the overrelease of pro-inflammatory cytokines such as IL-1␤, IL-6, and TNF-␣ (6).
The balance between skeletal muscle protein synthesis and degradation determines skeletal muscle mass. Muscle atrophy occurs when the degradation rate is higher than the synthesis rate (9) . Instead of measuring the skeletal protein synthesis and degradation directly, we analyzed the indicators of muscle protein mass and protein synthesis capacity, and the markers of skeletal protein degradation or muscle atrophy. The ratio of protein/DNA is a sensitive indicator of muscle protein mass (6) . The ratio of RNA/DNA reflects the cell capacity for protein synthesis (38) . The muscle-specific ubiquitin ligases MAFbx and MuRF1, two key proteins in the ubiquitin-proteasome proteolytic pathway (UPP), are the markers of skeletal muscle atrophy (20) . In our present experiment, dietary supplementation of 1.0 and 2.0% glycine increased protein/DNA ratio in gastrocnemius and LD muscles above the saline control, indicating that glycine increased muscle protein mass. Also, dietary supplementation of 1.0 or 2.0% glycine increased protein content and RNA/DNA ratios in gastrocnemius or LD muscles above the saline control, which indicates that glycine enhanced protein synthesis capacity. In addition, dietary supplementation of 1.0 and 2.0% glycine resulted in lower mRNA expression of MuRF1 in gastrocnemius muscle than the LPS control, and even lower mRNA expression of MAFbx in gastrocnemius muscle than the saline control, suggesting glycine inhibited the expression of muscle atrophy-associated genes and thus inhibited protein degradation. Similar to our data, Caldow et al. (5) reported that glycine administration during calorie restriction protected against further muscle loss in obese mice. In addition, Ham et al. (17) showed that glycine supplementation alleviated skeletal muscle wasting and reduced the expression of genes associated with muscle protein breakdown (MuRF1, MAFbx, LC3B, and BNIP3) in a mouse model of cancer cachexia. Moreover, Nakashima et al. (32) found that orally administered glycine suppressed myofibrillar proteolysis and expression of proteolytic-related genes (MAFbx, proteasome C2 subunit, m-calpain large subunit, and cathepsin B) of skeletal muscle in chicks under normal physiological conditions. However, unexpectedly, our data showed that glycine supplementation resulted in decreased muscle DNA content compared with the LPS or saline control. In fact, there are multiple pathways for glycine utilization to generate purines (RNA and DNA), and protein synthesis depends on purines (16) . The reason for this discrepancy, which waits for further investigation, is unclear.
Muscle growth is controlled by the IGF-1/Akt pathway through its downstream effectors mTOR and FOXO (31) . Akt, a serine/threonine protein kinase, induces protein synthesis by phosphorylating and activating mTOR. mTOR is a serine/ threonine protein kinase that regulates cell growth, protein synthesis, and autophagy-mediated proteolysis (40) . Through serving as a master modulator of protein synthesis, mTOR controls the translation initiation machinery in cells via phosphorylation and activation of the 70-kDa ribosomal protein S6 kinase-1 (S6K1) and via phosphorylation and inactivation of the eukaryotic initiation factor 4E inhibitor, 4E-BP1 (40) , and drives protein synthesis (54) . In addition, Akt also inhibits muscle protein degradation by phosphorylation and inactivation of the FOXO family of transcription factors (34) . Phosphorylation and inactivation of FOXO leads to transcriptional inhibition of FOXO target genes, i.e., MAFbx and MuRF1, and consequently results in an inhibition in protein degradation (55) .
In our present study, dietary supplementation of 1.0 or 2.0% glycine restored the ratios of p-Akt/t-Ak, p-mTOR/t-mTOR, and p-4E-BP1/t-4E-BP1 in gastrocnemius muscle near the saline control, or even increased them above the saline control, which is consistent with increased protein content and protein/ DNA and RNA/DNA ratios in muscles. Glycine has been shown to activate the Akt-mTOR signaling pathway in pig small intestinal epithelial cells (54) as well as in Madin-Darby canine kidney epithelial cells (21) in the absence of stress or stimulation. In addition, glycine supplementation restored the mRNA expression of FOXO1 in gastrocnemius and LD muscles and the ratio of p-FOXO1/t-FOXO1 in LD muscle near the saline control, which is concurrent with lower MAFbx and MuRF1 mRNA expression in muscles. Until now the research on glycine regulating FOXO signaling was lacking. Based on the published literature and our observations, the stimulatory effects of glycine on muscle protein mass are closely associated with activating mTOR signaling and/or inhibiting FOXO1/UPP signaling via activating Akt.
Activation of skeletal muscle inflammatory signaling pathways plays a key role in muscle atrophy during sepsis and infection (12) . TLRs and NODs are important protein families of inflammatory signaling pathways. They play a critical role in the detection of invading pathogens and the induction of innate antibacterial and inflammatory responses by recognizing PAMPs (15, 23) . Multiple TLRs and NODs are expressed in the skeletal muscle cells (12, 43) . Activation of TLRs or NODs by binding with their specific PAMPs triggers downstream intracellular signaling pathways that lead to NF-B activation, resulting in expression and release of pro-inflammatory cytokines (15) . Increased levels of pro-inflammatory cytokines, both in the circulation as well as locally at the level of the skeletal muscle, play a key role in the pathophysiology of muscle wasting (36) . Pro-inflammatory cytokines reduces skeletal muscle protein synthesis and increase muscle protein degradation directly (36) . In addition, pro-inflammatory cytokines induce muscle atrophy indirectly through alterations of Akt-mTOR-FOXO pathways (9) .
In our current experiment, concurrent with enhanced muscle protein mass, dietary supplementation of 1.0 and 2.0% glycine resulted in lower TNF-␣ concentration in plasma and lower mRNA expression of TNF-␣ in gastrocnemius and LD muscles than in the LPS control. Multiple studies have demonstrated that glycine supplementation results in activation of glycinegated chloride (Cl Ϫ ) channels in inflammatory cells, mediating an influx of Cl Ϫ into the cell, thereby making voltage-gated Values are means Ϯ SE, n ϭ 6 (1 pig/pen). Labeled means in a row without a common letter differ, P Ͻ 0.05. IRAK1, IL-1 receptor-associated kinase 1; LD, longissimus dorsi; MyD88, myeloid differentiation factor 88; NF-B, nuclear factor-B; NOD, nucleotide-binding oligomerization domain protein; RIPK2, receptor-interacting serine/threonine-protein kinase 2; TLR, Toll-like receptor; TNF-␣, tumor necrosis factor-␣; TRAF6, TNF receptor-associated factor 6.
Ca 2ϩ channels more difficult to open and alleviating the increases in [Ca 2ϩ ] i , cytokine production, and systemic inflammation in several models of diseases (4, 48, 59 ). In addition, Ham et al. (17) reported that glycine attenuated the increase of muscle IL-6 mRNA expression and macrophage infiltration in a mouse model of cancer cachexia. In the current study, consistent with the decreased plasma and muscle TNF-␣ concentrations, dietary supplementation of 1.0 or 2.0% glycine resulted in lower mRNA expresson of TLR4 and its downstream molecules (MyD88, IRAK1, and TRAF6), and NOD2 and its downstream adaptor molecule (RIPK2) in gastrocnemius muscle, and MyD88, TRAF6, and NOD2 in LD muscle compared with LPS control. Glycine has been shown to dampen TLR4 signaling induced by inflammatory stimulators (18, 41, 57) . Xu et al. (57) reported that glycine alleviated LPS-induced liver injury by attenuating the activation of TLR4/NF-B/TNF-␣ signaling in Kupffer cells. Hasegawa et al. (18) found that glycine inhibited NF-B activation, IB␣ degradation, CD62E (E-selectin) expression, and IL-6 production induced by TNF-␣ in human coronary arterial endothelial cells, suggesting that glycine exhibited anti-inflammatory effects during endothelial inflammation. However, glycine has no effect on TLR4 signaling and/or pro-inflammatory cytokines in the absence of stress or inflammatory stimulant (41, 48, 57) . Until now, research about glycine regulating NOD signaling has been lacking. Based on the previous studies and our observations, the beneficial roles of dietary glycine supplementation on muscle protein mass are closely associated with attenuating the increased expression of muscle pro-inflammatory cytokines through suppressing the activation of the TLR4 and/or NOD2 signaling pathways.
It has been well documented that dynamic changes occur in gene expression of pro-inflammatory cytokines, phosphorylation or dephosphorylation of signaling proteins, and synthesis or degradation of protein in muscles after administration with LPS (13, 14, 44) . Thus, determinations taken only at a single time point (4 h) are probably not adequate to investigate the roles of these pro-inflammatory cytokines and signaling proteins in LPS-caused muscle atrophy. In addition, the progression of muscle atrophy is more of a long-term physiological response rather than a short-term acute response (2, 10) . Thus a more chronic model of LPS challenge is better to study muscle atrophy than the acute model of LPS challenge used in our study. In our future research, we plan to collect samples at multiple time points to investigate the time-dependent function of glycine on the dynamic interplay and the long-term effect of glycine on muscle atrophy in a chronic LPS-challenged situation. We also plan to measure muscle mass, protein synthesis, and degradation directly in our pig models. Interestingly, in our study the effects of dietary glycine supplementation or LPS challenge on some of muscle measurements differed between gastrocnemius and LD muscles. This may be related to different anatomy and physiology among the various segments of muscles (35) .
Perspectives and Significance
Dietary glycine supplementation enhances muscle protein mass. The beneficial roles of glycine on the muscle are closely associated with 1) activating mTOR signaling and/or inhibiting FOXO1/UPP signaling via activating Akt and 2) attenuating the increased expression of muscle pro-inflammatory cytokines through suppressing the activation of the TLR4 and/or NOD2 signaling pathways.
